These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Nitrosamine Contamination in Pharmaceuticals: Threat, Impact, and Control. Tuesuwan B; Vongsutilers V J Pharm Sci; 2021 Sep; 110(9):3118-3128. PubMed ID: 33989680 [TBL] [Abstract][Full Text] [Related]
25. Mutagenic Azido Impurities in Drug Substances: A Perspective. Chourasiya SS; Kathuria D; Kumar V; Ranbhan KJ Ther Innov Regul Sci; 2024 Nov; 58(6):1159-1171. PubMed ID: 38954240 [TBL] [Abstract][Full Text] [Related]
26. NDSRIs Crisis in Pharmaceuticals; Insights on Formation Pathways, Root Causes, Risk Management, and Novel Analytical Techniques. P R HV; Kandula DR; Gunta U; Kumar G; Deka R; Chiriki DS; Chethan KS; Bannimath N; Yadav T; Beeraka NM; Gurupadayya BM Curr Med Chem; 2024 Sep; ():. PubMed ID: 39279119 [TBL] [Abstract][Full Text] [Related]
27. Managing the microbiological quality of pharmaceutical excipients. Cundell AM PDA J Pharm Sci Technol; 2005; 59(6):381-95. PubMed ID: 16471425 [TBL] [Abstract][Full Text] [Related]
28. Strategies for Assessing Acceptable Intakes for Novel Ponting DJ; Dobo KL; Kenyon MO; Kalgutkar AS J Med Chem; 2022 Dec; 65(23):15584-15607. PubMed ID: 36441966 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of the nitrosamine impurities of ACE inhibitors using computational, in vitro, and in vivo methods demonstrate no genotoxic potential. Cheung J; Dobo K; Zhang S; Nudelman R; Schmidt F; Wenzel J; Czich A; Schuler M Environ Mol Mutagen; 2024 Jul; 65(6-7):203-221. PubMed ID: 39180320 [TBL] [Abstract][Full Text] [Related]
30. Revisiting the Landscape of Potential Small and Drug Substance Related Nitrosamines in Pharmaceuticals. Burns MJ; Ponting DJ; Foster RS; Thornton BP; Romero NE; Smith GF; Ashworth IW; Teasdale A; Simon S; Schlingemann J J Pharm Sci; 2023 Dec; 112(12):3005-3011. PubMed ID: 37805074 [TBL] [Abstract][Full Text] [Related]
31. Retrospective application of ICH M7 to anti-hypertensive drugs in Brazil: Risk assessment of potentially mutagenic impurities. Waechter F; Falcao Oliveira AA; Borges Shimada AL; Bernes Junior E; de Souza Nascimento E Regul Toxicol Pharmacol; 2024 Aug; 151():105669. PubMed ID: 38936796 [TBL] [Abstract][Full Text] [Related]
33. ICH Q3D Drug Product Elemental Risk Assessment: The Use of An Elemental Impurities Excipients Database. Torres S; Boetzel R; Gatimu E; Gomes DZ; King F; Kocks G; Jones R; Day C; Lewen N; Harris L; Teasdale A J Pharm Sci; 2022 May; 111(5):1421-1428. PubMed ID: 34673095 [TBL] [Abstract][Full Text] [Related]
34. Excipient-related impurities in liposome drug products. Wang C; Gamage PL; Jiang W; Mudalige T Int J Pharm; 2024 May; 657():124164. PubMed ID: 38688429 [TBL] [Abstract][Full Text] [Related]
35. Reactive impurities in excipients: profiling, identification and mitigation of drug-excipient incompatibility. Wu Y; Levons J; Narang AS; Raghavan K; Rao VM AAPS PharmSciTech; 2011 Dec; 12(4):1248-63. PubMed ID: 21948318 [TBL] [Abstract][Full Text] [Related]
36. Simultaneous detection of nitrosamines and other sartan-related impurities in active pharmaceutical ingredients by supercritical fluid chromatography. Schmidtsdorff S; Schmidt AH J Pharm Biomed Anal; 2019 Sep; 174():151-160. PubMed ID: 31174128 [TBL] [Abstract][Full Text] [Related]
37. Analysis of genotoxic N-nitrosamines in active pharmaceutical ingredients and market authorized products in low abundance by means of liquid chromatography - tandem mass spectrometry. Vogel M; Norwig J J Pharm Biomed Anal; 2022 Sep; 219():114910. PubMed ID: 35779354 [TBL] [Abstract][Full Text] [Related]
38. A perspective on testing of existing pharmaceutical excipients for genotoxic impurities. Brusick DJ Regul Toxicol Pharmacol; 2009 Nov; 55(2):200-4. PubMed ID: 19607870 [TBL] [Abstract][Full Text] [Related]
39. Nitrosamine Impurities in Herbal Formulations: A Review of Risks and Mitigation Strategies. Shekhar NR; Nagappan K; Singh MT; Dhanabal SP Drug Res (Stuttg); 2023 Oct; 73(8):431-440. PubMed ID: 37487523 [TBL] [Abstract][Full Text] [Related]
40. Parts per billion of nitrite in microcrystalline cellulose by ion chromatography mass spectrometry with isotope labeled internal standard. Zhu K; Kerry M; Serr B; Mintert M J Pharm Biomed Anal; 2023 Oct; 235():115648. PubMed ID: 37611458 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]